HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Refractory monosymptomatic nocturnal enuresis: a combined stepwise approach in childhood and follow-up into adolescence, with attention to the clinical value of normalizing bladder capacity.

AbstractOBJECTIVE:
To assess the importance of normalizing bladder capacity to the age-expected capacity in children with refractory monosymptomatic nocturnal enuresis (MNE), and to evaluate the long-term results when these children grow into adolescence.
PATIENTS AND METHODS:
The study included 34 children with refractory MNE; all were treated > 5 years earlier for their MNE using a combined stepwise approach, consisting of retention control training, oxybutynin and an enuresis alarm. Data were obtained on their enuretic state, night-time voiding behaviour and bladder capacity, from a questionnaire and a voiding chart.
RESULTS:
Before starting treatment, all patients had a bladder capacity that was too small for their age. After the combined stepwise approach, MNE improved in all patients and 24 (71%) were cured. Although the bladder capacity was increased to the age-expected capacity in 26 (76%), most woke at night to void. Currently, at a mean of 7.7 years after the primary treatment, 28 (82%) of the patients are completely dry at night, of whom 15 (54%) arouse to void for 35% of the nights. Six patients (18%) still have some enuretic episodes. Only those who were dry after primary treatment and remained dry had a normal age-expected increase in bladder capacity. For all others there was a decrease in age-related bladder capacity.
CONCLUSIONS:
In patients with refractory MNE, a combined stepwise approach improves and may even eliminate enuresis, but normal night-time bladder behaviour in adolescence and adulthood is only achieved in some. Furthermore, about a fifth still have some enuretic episodes.
AuthorsAlexandra Vermandel, Stefan de Wachter, Jean-Jacques Wyndaele
JournalBJU international (BJU Int) Vol. 96 Issue 4 Pg. 629-33 (Sep 2005) ISSN: 1464-4096 [Print] England
PMID16104923 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Cholinergic Antagonists
  • Mandelic Acids
  • oxybutynin
Topics
  • Adolescent
  • Biofeedback, Psychology
  • Child
  • Child, Preschool
  • Cholinergic Antagonists (therapeutic use)
  • Combined Modality Therapy
  • Enuresis (drug therapy, pathology, therapy)
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Mandelic Acids (therapeutic use)
  • Physical Therapy Modalities
  • Prospective Studies
  • Treatment Outcome
  • Urinary Bladder (pathology)
  • Urination

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: